Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and fulvestrant

bromocriptine has been researched along with fulvestrant in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Abu Khalaf, R; Abu Sheikha, G; Bustanji, Y; Taha, MO1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Arita, J; Ishida, M; Izawa, M; Mitsui, T1
Freudenberg, JM; Fullenkamp, AN; Ho, SM; Medvedovic, M; Szeto, CY; Tam, NN1
Bai, J; Gui, S; Zhang, Y1
Bai, J; Lan, X; Li, C; Li, Z; Liu, Q; Wu, Y; Yu, G; Zhang, Y; Zong, X1
Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K1

Reviews

1 review(s) available for bromocriptine and fulvestrant

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for bromocriptine and fulvestrant

ArticleYear
Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Cholesterol Ester Transfer Proteins; Drug Discovery; Hydrogen Bonding; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; ROC Curve

2010
Absence of ligand-independent transcriptional activation of the estrogen receptor via the estrogen response element in pituitary lactotrophs in primary culture.
    The Journal of steroid biochemistry and molecular biology, 2010, Volume: 118, Issue:1-2

    Topics: Adenoviridae; Animals; Bromocriptine; Butadienes; Cell Line, Tumor; Cells, Cultured; Colforsin; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, Reporter; Insulin-Like Growth Factor I; Integrases; Isoquinolines; Lactotrophs; Ligands; Luciferases; Nitriles; Pituitary Gland, Anterior; Prolactin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Estrogen; Response Elements; Sulfonamides; Thymidine Kinase; Transcriptional Activation; Transduction, Genetic

2010
Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia.
    Molecular endocrinology (Baltimore, Md.), 2010, Volume: 24, Issue:11

    Topics: Animals; Bromocriptine; Calgranulin B; Cell Proliferation; Chemokine CXCL13; Epithelial Cells; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Interleukin-1beta; Male; Prolactin; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Testosterone

2010
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:5

    Topics: Adult; Animals; beta Catenin; Bromocriptine; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Rats; Young Adult

2013
The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
    Molecular and cellular endocrinology, 2015, Feb-15, Volume: 402

    Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Phosphorylation; Pituitary Neoplasms; Prolactinoma; Protein Processing, Post-Translational; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Young Adult

2015
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
    International journal of medical sciences, 2020, Volume: 17, Issue:18

    Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult

2020